NinePointTwo Capital’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-49,325	Closed	-$281K	–	278
2023 Q1	$281K	Buy	49,325 +36,729	+292%	+$209K	0.11%	55
2022 Q4	$127K	Buy	+12,596	New	+$127K	0.05%	166